34.04
Schlusskurs vom Vortag:
$35.46
Offen:
$33.88
24-Stunden-Volumen:
372.82K
Relative Volume:
0.83
Marktkapitalisierung:
$1.57B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$-20.76M
KGV:
-74.00
EPS:
-0.46
Netto-Cashflow:
$151.63M
1W Leistung:
-3.71%
1M Leistung:
-9.78%
6M Leistung:
-18.00%
1J Leistung:
+23.47%
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Vergleichen Sie OMCL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OMCL
Omnicell Inc
|
34.04 | 1.57B | 1.08B | -20.76M | 151.63M | -0.46 |
![]()
VEEV
Veeva Systems Inc
|
221.49 | 36.04B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
54.58 | 10.24B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
46.17 | 7.95B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
82.97 | 7.18B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
36.98 | 6.37B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
2024-01-03 | Eingeleitet | Barclays | Underweight |
2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-09-26 | Bestätigt | Wells Fargo | Underweight |
2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2022-09-09 | Eingeleitet | BofA Securities | Buy |
2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
2021-06-09 | Eingeleitet | JP Morgan | Neutral |
2021-05-24 | Eingeleitet | BTIG Research | Buy |
2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
2020-12-08 | Eingeleitet | Berenberg | Buy |
2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2020-07-07 | Eingeleitet | Stephens | Overweight |
2020-02-07 | Bestätigt | Dougherty & Company | Buy |
2019-11-21 | Bestätigt | Dougherty & Company | Buy |
2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
2019-03-07 | Bestätigt | Dougherty & Company | Buy |
2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
2017-09-05 | Bestätigt | The Benchmark Company | Buy |
2017-07-28 | Bestätigt | Dougherty & Company | Buy |
2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
2016-12-06 | Bestätigt | The Benchmark Company | Buy |
2016-07-07 | Bestätigt | FBR Capital | Outperform |
2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
2015-10-30 | Bestätigt | FBR Capital | Outperform |
2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
OMCL CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to Make a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against Omnicell Inc. - ACCESS Newswire
Pharmacy Automation Market to Witness Remarkable Growth with - openPR.com
Consolidation at Omnicell - Pharmacy Magazine
Is The Market Rewarding Omnicell, Inc. (NASDAQ:OMCL) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - Yahoo Finance
India Pharmacy Automation Market Competition, Forecast & - GlobeNewswire
Omnicell (NASDAQ:OMCL) Downgraded to Hold Rating by StockNews.com - MarketBeat
Omnicell Names Veteran Surgical Robotics Exec as Its New CTO - Dallas Innovates
Omnicell Appoints New CTO to Drive Technological Innovation - Zenopa
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term - Yahoo Finance
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer - EnterpriseTalk
Omnicell appoints Perry Genova as new CTO By Investing.com - Investing.com South Africa
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Offi - GuruFocus
Omnicell appoints Perry Genova as new CTO - Investing.com India
Omnicell appoints Perry Genova as Chief Technology Officer -March 24, 2025 at 04:30 pm EDT - MarketScreener
Pharmacy Automation Systems Market is expected to grow at a CAGR - openPR.com
Healthcare Tech Expert with 25-Year Track Record Takes Tech Helm at Omnicell - Stock Titan
Pharmacy Automation Market Future Business Opportunities - openPR.com
Long Term Trading Analysis for (OMCL) - news.stocktradersdaily.com
What Analysts Are Saying About Omnicell Stock - Benzinga
Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)? - simplywall.st
Omnicell CEO Randall Lipps buys $349,874 in stock By Investing.com - Investing.com Australia
Omnicell CEO Randall Lipps buys $349,874 in stock - Investing.com India
Omnicell, Inc. (NASDAQ:OMCL) Given Average Recommendation of “Hold” by Brokerages - Defense World
Omnicell CFO Nchacha Etta to step down in September By Investing.com - Investing.com Australia
Omnicell's (NASDAQ:OMCL) Earnings Seem To Be Promising - Yahoo Finance
Omnicell Chief Financial Officer Nchacha Etta to Retire - citybiz
Fort Worth-Based Omnicell CFO Nchacha Etta to Step Down as Company Initiates National Search - Fort Worth Inc.
BofA cuts Omnicell stock target to $38, maintains neutral rating By Investing.com - Investing.com UK
Omnicell Announces Chief Financial Officer Transition - 01Net
Omnicell CFO to step down, co reiterates first quarter and full year outlook -March 12, 2025 at 10:28 am EDT - Marketscreener.com
Omnicell CFO to step down, co reiterates first quarter and full year outlook - TradingView
Omnicell, Inc. Announces Step Down of Nchacha Etta as Executive Vice President Effective September 15, 2025 - Marketscreener.com
Omnicell's CFO Nchacha Etta to Step Down; Reaffirms Q1, Fiscal 2025 Guidance -March 12, 2025 at 09:20 am EDT - Marketscreener.com
Omnicell CFO Nchacha Etta to step down in September - Investing.com
Omnicell CFO set to depart By Investing.com - Investing.com Canada
Omnicell CFO Nchacha Etta to step down - TipRanks
Omnicell CFO Nchacha Etta Announces Departure - TipRanks
OMCLOmnicell Com Latest Stock News & Market Updates - StockTitan
Omnicell, Inc. to Host Earnings Call - ACCESS Newswire
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Bank of New York Mellon Corp - Defense World
QRG Capital Management Inc. Sells 353 Shares of Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell (NASDAQ:OMCL) Raised to “Buy” at StockNews.com - Defense World
Omnicell Gains 41.6% in a Year: What's Driving the Stock? - MSN
Omnicell CEO secures employment agreement through 2027 By Investing.com - Investing.com Canada
Omnicell CEO secures employment agreement through 2027 - Investing.com
Omnicell Secures CEO Randall Lipps Through 2027 - TipRanks
Medication Management System Market Is Booming Worldwide - openPR
Omnicell Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
What is Zacks Research’s Forecast for Omnicell Q3 Earnings? - Defense World
FY2027 EPS Forecast for Omnicell Decreased by Analyst - Defense World
Omnicell FY2027 EPS Estimate Reduced by Zacks Research - MarketBeat
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):